A carregar...
OS01.5 Development of TERT-targeting therapy using eribulin mesylate in mouse glioblastoma model
Introduction: Despite of recent extensive genome analysis, no effective molecular targeting therapy has been successfully developed in patients with glioblastomas (GBMs). Approximately 60–80% of GBM harbour mutations in the promoter region of telomerase reverse transcriptase (TERT) that leads to upr...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463620/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|